In the filing, Dr. Wiesel reportedly said his patented invention took “pioneering steps” in creating a system for atrial fibrillation detection based on monitoring “irregular pulse rhythms from a success of time intervals.” He filed the lawsuit to receive royalties from Apple for its use of the alleged copycat technology and to prevent Apple from using the technology without his permission.
Dr. Wiesel claimed in the lawsuit that he first provided Apple with detailed information about his patent in September 2017, Bloomberg reports, but that the company has “refused to negotiate in good faith to avoid this lawsuit.”
Apple did not respond to Bloomberg‘s request for comment.
More articles on health IT:
36 hospitals, health systems that partnered with big tech in 2019
Tech-based population health strategy reduces readmissions, shortens stays
AHA critiques FDA’s expanded regulation of clinical decision support software
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
